The tweet was deleted by the author.
But we saved everything 🙂.
Solid Biosciences will participate in the Jefferies Global Healthcare Conference on June 3, where President and CEO Bo Cumbo is scheduled for a fireside chat at 7:35 AM ET.
The company announced that the session will be accessible via a live webcast. This engagement at one of the sector’s leading investor events underscores Solid Biosciences focus on genetic medicine and its continuing bid to communicate its vision to health care stakeholders.
Solid Biosciences recently presented insights into its SGT-003 gene therapy candidate for Duchenne muscular dystrophy at a leading scientific congress, according to a company update. Earlier in May, Chief Medical Officer Carl Morris discussed advances in targeted genetic therapy delivery at FierceBiotechWeek in Boston during a dedicated session. These appearances reinforce the company’s ongoing engagement at major industry events.